15188 Clinical responses by self-reported PsA status at baseline among patients with moderate to severe psoriasis treated with guselkumab versus secukinumab: Week 48 results from the ECLIPSE study

https://doi.org/10.1016/j.jaad.2020.06.212Get rights and content

References (0)

Cited by (0)

Commercial disclosure: This study was sponsored by Janssen Research & Development.

View full text